Skip to main content
V

Valeris

Valeris is a life sciences commercialization partner formed in 2025, offering patient support, market access intelligence, reimbursement support, consulting and provider engagement tools.

Valeris is a fully integrated life sciences commercialization partner that works across the healthcare value chain, covering the pharmaceutical, biotechnology and medical device sectors. The company was formed in May 2025 through the merger of PharmaCord and Mercalis (formerly TrialCard), bringing together expertise in commercialization with technology aimed at improving the patient experience and medication adherence.

Its work is organised around five service lines. Patient support services help patients access and adhere to critical medications, while field reimbursement support assists with reimbursement for pharmaceutical, biotech and medical device products. Market access intelligence provides data and strategic insights to help life sciences companies commercialise new products, and strategic consulting is intended to shape successful commercial life cycles. Healthcare provider engagement tools enable engagement with healthcare providers on behalf of life sciences companies.

Technical capabilities are concentrated in three areas: data analytics and strategic insights, healthcare provider engagement tools, and patient support technology. The company states a commitment to patient care and describes an approach combining industry expertise with technology. Further details on team size, funding and geographic footprint were not disclosed.

1 Open job